JT Granton, MT Naughton, DC Benard, PP Liu, RS Goldstein and TD Bradley
Queen Elizabeth Hospital Sleep Research Laboratory, Toronto, Ontario, Canada.

Patients with congestive heart failure (CHF) suffer from respiratory muscle weakness which may contribute to dyspnea. Nasal continuous positive airway pressure (NCPAP) can improve left ventricular ejection fraction (LVEF) and reduce dyspnea in patients with CHF and Cheyne- Stokes respiration with central sleep apnea (CSR-CSA) but its effects on respiratory muscle strength are not known. We therefore studied the effects of NCPAP on maximal inspiratory and expiratory pressures (MIP and MEP, respectively), LVEF, dyspnea, and fatigue in patients with chronic CHF and CSR-CSA over 3 mo. Eight patients were randomized to control and nine to nightly NCPAP. There were no significant changes in any of these factors in the control group during the study. In contrast, among the NCPAP group, MIP increased from 79.3 +/- 8.1 to 90.7 +/- 10.4 cm H2O (mean +/- SEM; p < 0.02), LVEF increased from 24.0 +/- 4.0 to 32.6 +/- 6.6% (p < 0.02) and symptoms of dyspnea and fatigue were alleviated. However, MEP did not change. In addition, the number of apneas and hypopneas decreased from 49 +/- 11 to 17 +/- 7 per hour of sleep (p < 0.001) and mean low Sao2 during sleep increased from 87.9 +/- 1.0 to 93.0 +/- 1.0% (p < 0.01). Our data indicate that nightly application of NCPAP in patients with CHF and CSR-CSA improves inspiratory muscle strength and LVEF, and relieves dyspnea and fatigue.

This article has been cited by other articles:

				M. Arzt and T. D. Bradley Treatment of Sleep Apnea in Heart Failure Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1300 - 1308. [Abstract] [Full Text] [PDF]

				C Philippe, M Stoica-Herman, X Drouot, B Raffestin, P Escourrou, L Hittinger, P-L Michel, S Rouault, and M-P d'Ortho Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period Heart, March 1, 2006; 92(3): 337 - 342. [Abstract] [Full Text] [PDF]

				S. Javaheri Acetazolamide Improves Central Sleep Apnea in Heart Failure: A Double-Blind, Prospective Study Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 234 - 237. [Abstract] [Full Text] [PDF]

				L J Cormican and A Williams Sleep disordered breathing and its treatment in congestive heart failure Heart, October 1, 2005; 91(10): 1265 - 1270. [Abstract] [Full Text] [PDF]

				R. Naeije Breathing more with weaker respiratory muscles in pulmonary arterial hypertension Eur. Respir. J., January 1, 2005; 25(1): 6 - 8. [Full Text] [PDF]

				F. J. Meyer, D. Lossnitzer, A. V. Kristen, A. M. Schoene, W. Kubler, H. A. Katus, and M. M. Borst Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension Eur. Respir. J., January 1, 2005; 25(1): 125 - 130. [Abstract] [Full Text] [PDF]

				F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF]

				R. N. Khayat, A. Xie, A. K. Patel, A. Kaminski, and J. B. Skatrud Cardiorespiratory Effects of Added Dead Space in Patients With Heart Failure and Central Sleep Apnea Chest, May 1, 2003; 123(5): 1551 - 1560. [Abstract] [Full Text] [PDF]

				R. S. T. LEUNG and T. DOUGLAS BRADLEY Sleep Apnea and Cardiovascular Disease Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165. [Full Text] [PDF]

				A. T. Yan, T. D. Bradley, and P. P. Liu The Role of Continuous Positive Airway Pressure in the Treatment of Congestive Heart Failure Chest, November 1, 2001; 120(5): 1675 - 1685. [Abstract] [Full Text] [PDF]

				G.N. Willson, I. Wilcox, A.J. Piper, W.E. Flynn, M. Norman, R.R. Grunstein, and C.E. Sullivan Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep Eur. Respir. J., June 1, 2001; 17(6): 1250 - 1257. [Abstract] [Full Text] [PDF]

				C. Coirault, A. Hagege, D. Chemla, M.-D. Fratacci, C. Guerot, and Y. Lecarpentier Angiotensin-Converting Enzyme Inhibitor Therapy Improves Respiratory Muscle Strength in Patients With Heart Failure Chest, June 1, 2001; 119(6): 1755 - 1760. [Abstract] [Full Text] [PDF]

				F. J. Meyer, M. M. Borst, C. Zugck, A. Kirschke, D. Schellberg, W. Kubler, and M. Haass Respiratory Muscle Dysfunction in Congestive Heart Failure : Clinical Correlation and Prognostic Significance Circulation, May 1, 2001; 103(17): 2153 - 2158. [Abstract] [Full Text] [PDF]

				D. Kindgen-Milles, R. Buhl, A. Gabriel, H. Bohner, and E. Muller Nasal Continuous Positive Airway Pressure: A Method to Avoid Endotracheal Reintubation in Postoperative High-risk Patients With Severe Nonhypercapnic Oxygenation Failure Chest, April 1, 2000; 117(4): 1106 - 1111. [Abstract] [Full Text] [PDF]

				S. L. Krachman, G. E. D’Alonzo, T. J. Berger, and H. J. Eisen Comparison of Oxygen Therapy With Nasal Continuous Positive Airway Pressure on Cheyne-Stokes Respiration During Sleep in Congestive Heart Failure* Chest, December 1, 1999; 116(6): 1550 - 1557. [Abstract] [Full Text] [PDF]

				P. D. HUGHES, M. I. POLKEY, M. LOU HARRIS, A. J. S. COATS, J. MOXHAM, and M. GREEN Diaphragm Strength In Chronic Heart Failure Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 529 - 534. [Abstract] [Full Text]

				R. Tkacova, F. Rankin, F. S. Fitzgerald, J. S. Floras, and T. D. Bradley Effects of Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Left Ventricular Afterload in Patients With Heart Failure Circulation, November 24, 1998; 98(21): 2269 - 2275. [Abstract] [Full Text] [PDF]

				M T Naughton Pathophysiology and treatment of Cheyne-Stokes respiration Thorax, June 1, 1998; 53(6): 514 - 518. [Full Text]